[Cervical myelography with water-soluble contrast medium (Metrizamide). Technique and preliminary results (author's transl)].
Use of a water-soluble contrast medium for cervical spinal diagnosis has become possible with the introduction of Metrizamide (Amipaqque). Injection of contrast at the C.1/2 level by a lateral approach results in excellent visualisation of the cervical theca with previously unobtainable detail. This technique, which is so far not well known, allows a rapid examination and when used with the new, well tolerated contrast media provides optimal diagnostic results.
D002574:Cervical Vertebrae; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging; D007463:Iodobenzoates; D008793:Metrizamide / Q000009:adverse effects; D009192:Myelography / Q000379:methods*; D010007:Osteochondritis / Q000000981:diagnostic imaging; D011187:Posture; D012996:Solutions; D013117:Spinal Cord Compression / Q000000981:diagnostic imaging; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging; D013126:Spinal Nerve Roots / Q000000981:diagnostic imaging; D014867:Water
D007463:Iodobenzoates; D012996:Solutions; D014867:Water; D008793:Metrizamide
Die zervikale Myelographie mit wasserlöslichem Kontrastmittel (Metrizamide). Technik und vorläufige Ergebnisse